SCHEMBL2881897

SCHEMBL2881897

CC(N)OC(=O)CC(O)(C(=O)O)c1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
HTR1A P08908 2/20 0.47
ADRA2B P18089 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2B P41595 1/20 0.47
KCNH2 Q12809 1/20 0.47
ALKBH5 Q6P6C2 1/20 0.35
HTR1B P28222 4/20 0.34
HTR1D P28221 3/20 0.34
POLB P06746 1/20 0.33
TSHR P16473 2/20 0.33
HPGD P15428 1/20 0.33
CHRM2 P08172 1/20 0.32
ADRA2A P08913 1/20 0.32
CHRM1 P11229 1/20 0.32
DRD1 P21728 1/20 0.32
SLC6A2 P23975 1/20 0.32
OPRM1 P35372 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2877321 0.84 HTR1A (0.46) LMNAHTR1AADRA2BHTR2AHTR2B
SCHEMBL2788456 0.79 LMNA (0.48) LMNAHTR1AADRA2BHTR2AHTR2B
SCHEMBL2788593 0.77 LMNA (0.51) LMNAHTR1AADRA2BHTR2AHTR2B
SCHEMBL2880030 0.75 LMNA (0.47) LMNAHTR1AADRA2BHTR2AHTR2B
SCHEMBL189975 0.74 HTR1A (0.58) LMNAHTR1AADRA2BHTR2AHTR2B
SCHEMBL2789287 0.72 HTR1A (0.58) LMNAHTR1AADRA2BHTR2AHTR2B
SCHEMBL13081208 0.70 LMNA (0.64) LMNAHTR1AADRA2BHTR2AHTR2B
SCHEMBL13081207 0.69 LMNA (0.66) LMNAHTR1AADRA2BHTR2AHTR2B
SCHEMBL189974 0.69 HTR1A (0.68) LMNAHTR1AADRA2BHTR2AHTR2B
Oxalic Acid SCHEMBL2788592 0.68 HTR1A (0.67) LMNAHTR1AADRA2BHTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010113183-A2 PROCESS FOR THE PREPARATION OF 1-[[[3-[2-(DIMETHYLAMINO)ETHYL]-1H-INDOL-5-YL]METHYL]SULFONYL] PYRROLIDINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS MSN LABORATORIES LIMITED (IN) 2010-10-07 WO disclosed